PMID- 29649221 OWN - NLM STAT- MEDLINE DCOM- 20180723 LR - 20221207 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 13 IP - 4 DP - 2018 TI - Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials. PG - e0194801 LID - 10.1371/journal.pone.0194801 [doi] LID - e0194801 AB - BACKGROUND: The comparison between long acting insulin analogues (LAIA) and human insulin (NPH) has been investigated for decades, with many randomized controlled trials (RCTs) and systematic reviews giving mixed results. This overlapping and contradictory evidence has increased uncertainty on coverage decisions at health systems level. AIM: To conduct an overview of systematic reviews and update existing reviews, preparing new meta-analysis to determine whether LAIA are effective for T1D patients compared to NPH. METHODS: We identified systematic reviews of RCTs that evaluated the efficacy of LAIA glargine or detemir, compared to NPH insulin for T1D, assessing glycated hemoglobin (A1C) and hypoglycemia. Data sources included Pubmed, Cochrane Library, EMBASE and hand-searching. The methodological quality of studies was independently assessed by two reviewers, using AMSTAR and Jadad scale. We found 11 eligible systematic reviews that contained a total of 25 relevant clinical trials. Two reviewers independently abstracted data. RESULTS: We found evidence that LAIA are efficacious compared to NPH, with estimates showing a reduction in nocturnal hypoglycemia episodes (RR 0.66; 95% CI 0.57; 0.76) and A1C (95% CI 0.23; 0.12). No significance was found related to severe hypoglycemia (RR 0.94; 95% CI 0.71; 1.24). CONCLUSION: This study design has allowed us to carry out the most comprehensive assessment of RCTs on this subject, filling a gap in diabetes research. Our paper addresses a question that is important not only for decision makers but also for clinicians. FAU - Laranjeira, Fernanda O AU - Laranjeira FO AD - Faculty of Health Sciences, University of Brasilia, Brasilia, Federal District, Brazil. FAU - de Andrade, Keitty R C AU - de Andrade KRC AUID- ORCID: 0000-0002-8882-6856 AD - Faculty of Medical Sciences, University of Brasilia, Brasilia, Federal District, Brazil. FAU - Figueiredo, Ana C M G AU - Figueiredo ACMG AD - Faculty of Health Sciences, University of Brasilia, Brasilia, Federal District, Brazil. FAU - Silva, Everton N AU - Silva EN AD - Faculty of Health Sciences, University of Brasilia, Brasilia, Federal District, Brazil. FAU - Pereira, Mauricio G AU - Pereira MG AD - Faculty of Medical Sciences, University of Brasilia, Brasilia, Federal District, Brazil. LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20180412 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) RN - 0 (Insulin, Long-Acting) RN - 0 (hemoglobin A1c protein, human) RN - 2ZM8CX04RZ (Insulin Glargine) RN - 4FT78T86XV (Insulin Detemir) SB - IM MH - Diabetes Mellitus, Type 1/*drug therapy MH - Glycated Hemoglobin/chemistry MH - Humans MH - Hypoglycemia/drug therapy MH - Hypoglycemic Agents/therapeutic use MH - Insulin Detemir/therapeutic use MH - Insulin Glargine/therapeutic use MH - Insulin, Long-Acting/*therapeutic use MH - Models, Statistical MH - Randomized Controlled Trials as Topic MH - Regression Analysis PMC - PMC5896894 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2018/04/13 06:00 MHDA- 2018/07/24 06:00 PMCR- 2018/04/12 CRDT- 2018/04/13 06:00 PHST- 2017/10/31 00:00 [received] PHST- 2018/03/10 00:00 [accepted] PHST- 2018/04/13 06:00 [entrez] PHST- 2018/04/13 06:00 [pubmed] PHST- 2018/07/24 06:00 [medline] PHST- 2018/04/12 00:00 [pmc-release] AID - PONE-D-17-38511 [pii] AID - 10.1371/journal.pone.0194801 [doi] PST - epublish SO - PLoS One. 2018 Apr 12;13(4):e0194801. doi: 10.1371/journal.pone.0194801. eCollection 2018.